Search 

Company aim is to produce high- tech medical solutions especially for reliable assessment and training of muscular strength.

Business idea is to offer solutions for safe and rapid recovery of patient’s functional ability in musculoskeletal rehabilitation enabling cost-effectiveness and increasing productivity in primary care profiting both end-user and health care provider.

The team know-how consist professional expertise on exercise physiology, engineering, as well as software and project management. In order to maximize full potential of product commercialization we are looking for complementary core expertise and supportive financing for successful products launch and internationalization efforts. 

Ferrosan Medical Devices comprises two companies that both provide a range of innovative products used by health care professionals in the fields of surgery and diagnostics. Our technology includes Biomaterials used as haemostatic agent for surgery to control bleeding, and miniature Electromechanics used in devices for minimally invasive surgery and drug delivery.

Fluence Therapeutics is commercializing photodynamic therapy for the treatment of psoriasis and other skin diseases.

We have successfully completed Phase Ia studies and are seeking funding for the completion of a Phase Ib/IIa proof of concept study in Tampere, Finland.

Current therapies are not adequate for the treatment of difficult cases of psoriasis.  Current light therapies use UV light, which is a known carcinogen, requires many treatments and results in premature photoaging.  Systemic pharmaceuticals globally suppress the immune system, resulting in increased rates of infection and certain kinds of cancers. 

Our therapy uses a novel photosensitizer which is activated by harmless red light and, unlike ALA PDT, does not result in pain or residual photosensitivity.  It can treat multiple, large lesions simultaneously.  It is totally inert unless activated by visible red light.  When activated, it preferentially kills activated t cells over other skin cells.

Mariachi Oy is a privately owned Finnish technology company specializing in development and contract manufacturing of advanced devices or instruments for professional use.

Our customers are recognized suppliers of medical devices, industrial systems and information technology. We focus on European customers with product portfolios comprising devices that range from hand-held to table-top units. More than 20 such customers are currently exporting devices developed and/or manufactured by Mariachi to more than 50 countries around the world.

Onesys Oy has an impressive track record in surgical and other clinical innovations. New developments and inventions broaden the applications of Onesys technology, with first products in the market, some ready for market and others at proof of concept phase. The business plan is based on investment milestones, sales and product spin-offs. Exit is M/A at three years or a clear plan for IPO at that time.